What does Dr.Kerssebeeck-Dr.Berends do?

Dr.Kerssebeeck-Dr.Berends is a specialist medical practice in Hasselt. Private Limited, started on 30 May 2008, 1 establishment.

What is the address of Dr.Kerssebeeck-Dr.Berends?

The registered office of Dr.Kerssebeeck-Dr.Berends is located at Nieuwe steenweg 38, 3500 Hasselt.

Is Dr.Kerssebeeck-Dr.Berends still active?

Yes. According to the CBE (3 October 2026) Dr.Kerssebeeck-Dr.Berends is active, legal situation “Normale toestand”, started on 30 May 2008.

Is Dr.Kerssebeeck-Dr.Berends registered on Peppol?

Yes, Dr.Kerssebeeck-Dr.Berends is registered on the Peppol network with ID 0208:0898434784.

What is the enterprise number of Dr.Kerssebeeck-Dr.Berends?

The enterprise number of Dr.Kerssebeeck-Dr.Berends is BE0898434784.

When was Dr.Kerssebeeck-Dr.Berends founded?

Dr.Kerssebeeck-Dr.Berends was founded on 30 May 2008.

Who are the directors of Dr.Kerssebeeck-Dr.Berends?

According to the 2025 annual accounts, the directors of Dr.Kerssebeeck-Dr.Berends are: NOOR BERENDS, BRAM KERSSEBEECK.

Is Dr.Kerssebeeck-Dr.Berends a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 May 2008; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr.Kerssebeeck-Dr.Berends make in 2025?

Dr.Kerssebeeck-Dr.Berends posted a profit after taxes of € 179,939 in financial year 2025.

What is the revenue of Dr.Kerssebeeck-Dr.Berends?

As a small company, Dr.Kerssebeeck-Dr.Berends is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 290,979.

Dr.Kerssebeeck-Dr.Berends (Private Limited) - Hasselt

Dossier Dr.Kerssebeeck-Dr.Berends, printed on 3 October 2026 from databakkes.be/en/0898434784/dr-kerssebeeck-dr-berends. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr.Kerssebeeck-Dr.Berends from Hasselt, company number BE0898434784, closed financial year 2025 with a result of € 179,939 after tax. For that financial year Dr.Kerssebeeck-Dr.Berends recorded a gross margin of € 290,979 and equity of € 612,780. Compared with financial year 2024, the result moved from € 148,916 to € 179,939. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Healthy

€ 612,780

▼ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 179,939

▲ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 291,794

▼ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 252,140 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 42,802

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 72,076

▼ 29% vs 2024

€ 30,095 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1,626

▼ 55% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 25,351

▼ 67% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 202,608 Gross margin 2022: € 202,608 First fiscal year in the series	€ 250,486 Gross margin 2023: € 250,486 ▲ 24% vs 2022 (€ 202,608) Favourable step	€ 253,499 Gross margin 2024: € 253,499 ▲ 1% vs 2023 (€ 250,486) Favourable step	€ 290,979 Gross margin 2025: € 290,979 ▲ 15% vs 2024 (€ 253,499) Favourable step	▲ 15%
Profit after taxes	€ 114,695 Profit after taxes 2022: € 114,695 First fiscal year in the series	€ 146,428 Profit after taxes 2023: € 146,428 ▲ 28% vs 2022 (€ 114,695) Favourable step	€ 148,916 Profit after taxes 2024: € 148,916 ▲ 2% vs 2023 (€ 146,428) Favourable step	€ 179,939 Profit after taxes 2025: € 179,939 ▲ 21% vs 2024 (€ 148,916) Favourable step	▲ 21%
Equity	€ 648,443 Equity 2022: € 648,443 First fiscal year in the series	€ 676,128 Equity 2023: € 676,128 ▲ 4% vs 2022 (€ 648,443) Favourable step	€ 684,981 Equity 2024: € 684,981 ▲ 1% vs 2023 (€ 676,128) Favourable step	€ 612,780 Equity 2025: € 612,780 ▼ 11% vs 2024 (€ 684,981) Unfavourable step	▼ 11%
Total debts	€ 156,976 Total debts 2022: € 156,976 First fiscal year in the series	€ 250,823 Total debts 2023: € 250,823 ▲ 60% vs 2022 (€ 156,976) Unfavourable step	€ 318,183 Total debts 2024: € 318,183 ▲ 27% vs 2023 (€ 250,823) Unfavourable step	€ 116,581 Total debts 2025: € 116,581 ▼ 63% vs 2024 (€ 318,183) Favourable step	▼ 63%
Cash	€ 377,640 Cash 2022: € 377,640 First fiscal year in the series	€ 198,347 Cash 2023: € 198,347 ▼ 47% vs 2022 (€ 377,640) Unfavourable step	€ 318,571 Cash 2024: € 318,571 ▲ 61% vs 2023 (€ 198,347) Favourable step	€ 291,794 Cash 2025: € 291,794 ▼ 8% vs 2024 (€ 318,571) Unfavourable step	▼ 8%
Land & buildings	€ 75,126 Land & buildings 2022: € 75,126 First fiscal year in the series	€ 48,312 Land & buildings 2023: € 48,312 ▼ 36% vs 2022 (€ 75,126) Unchanged	€ 35,454 Land & buildings 2024: € 35,454 ▼ 27% vs 2023 (€ 48,312) Unchanged	€ 23,636 Land & buildings 2025: € 23,636 ▼ 33% vs 2024 (€ 35,454) Unchanged	▼ 33%
Retained profit	€ 636,043 Retained profit 2022: € 636,043 First fiscal year in the series	€ 661,868 Retained profit 2023: € 661,868 ▲ 4% vs 2022 (€ 636,043) Favourable step	€ 670,721 Retained profit 2024: € 670,721 ▲ 1% vs 2023 (€ 661,868) Favourable step	€ 600,380 Retained profit 2025: € 600,380 ▼ 10% vs 2024 (€ 670,721) Unfavourable step	▼ 10%
Dividend	€ 40,190 Dividend 2022: € 40,190 First fiscal year in the series	€ 118,742 Dividend 2023: € 118,742 ▲ 195% vs 2022 (€ 40,190) Unchanged	€ 140,063 Dividend 2024: € 140,063 ▲ 18% vs 2023 (€ 118,742) Unchanged	€ 252,140 Dividend 2025: € 252,140 ▲ 80% vs 2024 (€ 140,063) Unchanged	▲ 80%
Bank debt	€ 89,875 Bank debt 2022: € 89,875 First fiscal year in the series	€ 128,879 Bank debt 2023: € 128,879 ▲ 43% vs 2022 (€ 89,875) Unfavourable step	€ 101,029 Bank debt 2024: € 101,029 ▼ 22% vs 2023 (€ 128,879) Favourable step	€ 72,076 Bank debt 2025: € 72,076 ▼ 29% vs 2024 (€ 101,029) Favourable step	▼ 29%
Balance sheet total	€ 805,418 Balance sheet total 2022: € 805,418 First fiscal year in the series	€ 926,952 Balance sheet total 2023: € 926,952 ▲ 15% vs 2022 (€ 805,418) Unchanged	€ 1,003,164 Balance sheet total 2024: € 1,003,164 ▲ 8% vs 2023 (€ 926,952) Unchanged	€ 729,361 Balance sheet total 2025: € 729,361 ▼ 27% vs 2024 (€ 1,003,164) Unchanged	▼ 27%

Key figures of Dr.Kerssebeeck-Dr.Berends, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr.Kerssebeeck-Dr.Berends?

What happened at Dr.Kerssebeeck-Dr.Berends in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 179,939 (▲ 21% vs 2024). Source: NBB ↗
Oct 25, 2008 New establishment in Hasselt. KBO
May 30, 2008 Start of the company according to the CBE. KBO
2008 NOOR BERENDS became a director. NBB
2008 BRAM KERSSEBEECK became a director. NBB

In short

From € 114,695 profit in 2022 to € 179,939 profit in 2025.

Paid € 274,057 in corporate taxes since 2022.

Best year ever: 2025, with € 179,939 profit.

Paid out € 551,135 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr.Kerssebeeck-Dr.Berends? We notify you, reason included.

Follow Dr.Kerssebeeck-Dr.Berends

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

NOOR BERENDS BRAM KERSSEBEECK

Dr.Kerssebeeck-Dr.Berends

Behind Dr.Kerssebeeck-Dr.Berends are NOOR BERENDS and BRAM KERSSEBEECK.

See the full network in the app

Directors

According to the 2025 annual accounts

NOOR BERENDS

Director

since 2008

BRAM KERSSEBEECK

Director

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Nieuwe steenweg 38

3500 Hasselt

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0898.434.784

VAT number

BE 0898.434.784

Registered office

Nieuwe steenweg 38, 3500 Hasselt

Names & denominations

Dr.Kerssebeeck-Dr.Berends

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 May 2008

Peppol

Active · Active since 12 May 2025

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr.Kerssebeeck-Dr.Berends

Financials

What happened to Dr.Kerssebeeck-Dr.Berends?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions